|
|
||||||||
| ABSTRACT |
|
|
|---|
2 = 80.2, P
0.0001). Within this group of infected children, 72.8% were infected with genotype 1, 18.4% with genotype 2, and 4.1% with a mixture of both genotypes, and 4.1% isolates were either unclassified or C. meleagridis. The prevalence was highest during the rainy months of April to June. Of the 532 children with persistent diarrhea, 166 (31.2%) had C. parvum compared with 278 (22.3%) of the 1,247 children with acute diarrhea (
2 = 15.8, P
0.0001). There was a significant association between C. parvum and malnutrition including stunting, being underweight, and wasting. Unfavorable outcome (death or failure to resolve within 14 days) occurred in 139 (72.8%) of the 191 children with C. parvum, and in only 65.1% of the 545 without (odds ratio = 1.117, 95% confidence interval = 1.0051.243, P = 0.05), Of the 191 children with C. parvum, 24 (12.6%) died, compared with 34 (6.2%) of the 545 without C. parvum (P = 0.005). Mortality rates were higher among children with severe dehydration and persistent diarrhea, and in stunted or underweight children infected with C. parvum. Among Ugandan children, cryptosporidiosis, which remains untreatable, is frequently associated with diarrhea and other serious and unfavorable consequences. | INTRODUCTION |
|
|
|---|
The mortality rate associated with persistent diarrhea in malnourished children is disproportionately high, accounting for up to 45% of diarrheal deaths in Bangladesh4, Brazil5, and in several African countries.3 A recent study in Uganda has shown that among children less than 30 months of age in rural and semi-urban areas, a high proportion were either stunted or underweight and one-fourth of them had diarrhea.6 It is possible that the high prevalence of malnutrition and concurrent infections are due to poor immune function and inadequate nutrition (Oriokot FM, Tumwine JK, unpublished data).
While the role of Cryptosporidium parvum as a cause of acute diarrhea in developing countries is well documented,7 its probable contribution to persistent diarrhea and malnutrition in children remains uncertain. While no therapy currently exists for infection with C. parvum, two recent, randomized, controlled clinical trials with nitazoxanide have shown promise.8,9 However, comprehensive studies on the prevalence of C. parvum in Uganda, and its contribution to chronic diarrhea and stunted growth and development have not been conducted. Therefore, the current study was designed to document the prevalence of diarrhea in children admitted to Mulago Hospital in Kampala, Uganda, establish the prevalence of cryptosporidiosis with acute and persistent diarrhea, and determine the association of the infection with stunted growth and malnutrition. We have also assessed the prevalence of C. parvum genotypes in infected children.
| MATERIALS AND METHODS |
|
|
|---|
Study design. This was a cross-sectional case-control study in which every three children with diarrhea were matched for age and sex with a child without diarrhea. The control children were included for the purpose of establishing whether there was a difference between the prevalence of C. parvum in children with diarrhea compared with those without diarrhea.
Inclusion criteria. Children 060 months old admitted to Mulago Hospital from November 1999 to January 2001 with acute or persistent diarrhea and whose caretakers consented to participate were entered into the study. Children without diarrhea in the previous 72-hour period were matched for age and sex and recruited as the controls.
Exclusion criteria. Children with dysentery, measles, or any form of cancer, or children whose parents or caretaker could not ascertain their age were excluded from the study.
Sample size determination. A formula by Kish was used to calculate the sample size.10 Assuming the prevalence of C. parvum to be 18%, and a margin of error of 1% and 95% confidence, a sample size of 2,202 was calculated for determining the prevalence of C. parvum.11 The sample for the case-control study was calculated using the formula of Fleiss.12 With 80% power and 95% confidence intervals and relative risk worth detecting at 1.52, the sample size of the affected population (children with diarrhea) was 1,399 and that of the controls (children without diarrhea) was 588. The prevalence of diarrhea due to C. parvum was estimated to occur in 12.2% of the children with diarrhea and in only 8% of the control children based on several other case-control studies.13
Recruitment and management. Eligible children were recruited up to a total of 15 children/day. The children were selected using systematic sampling by taking every sixth child with diarrhea. Due to resource constraints, it was not possible to follow-up all the children. Seven-hundred thirty-six randomly selected children were followed-up for two weeks. Five of the 15 children were selected every day for follow-up using simple random sampling.
All children had their clinical and nutritional status assessed. All patients were managed with appropriate fluid therapy. Some received antibiotics if they had concurrent infections such as respiratory infections.
Measurements. Measurements were carried out using international guidelines.14 Children were weighed to the nearest 100 grams using a hanging spring scale (Salter Weight-Tronx, Ltd., West Bromwich, United Kingdom) that was checked and adjusted daily. Children were weighed almost nude with only underpants retained for privacy. Height for children 2459 months old and length for those less than two years old were measured using adjustable wooden boards constructed locally according to specifications of the United Nations.12 Height was measured to the nearest 0.1 cm. Mid upper arm circumference was measured to the nearest 0.1 cm. The age of the child was ascertained from the child health card or baptismal or birth certificates. If none of these were available, age was assessed using a calendar of local events such as the 1996 general election. Background sociodemographic data was collected using a questionnaire.
Laboratory procedures. Stools were collected from enrolled children for diagnostic microbiology. Cryptosporidium oocysts were detected by modified acid fast staining of fecal smears and analysis by polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP). Fecal DNA was extracted from stool specimens and a PCR fragment from the Cryptosporidium oocyst cell wall protein gene was amplified.15 The PCR-RFLP assay provided a sensitive method for the detection of cryptosporidiosis in patients and allowed the genotyping of the C. parvum isolates. Over the first six months, some 650 stool samples were also examined by microscopy and PCR for Cyclospora, and by microscopy for Giardia and Entameba histolytica. However, due to the miniscule number of positive samples (one, two, and one, respectively), further testing for these pathogens was abandoned. No enteric viruses or bacteria were sought in these samples. The prevalence and contribution to diarrhea of the microsporidium Enterocytozoon bieneusi was also analyzed by PCR as previously reported.16
Data management. Data was processed using EPINUT in the Epi-Info version 6.0 computer statistical package17 and SPSS software (SPSS, Inc., Chicago, IL). Data were summarized using frequency tables, bar charts, histograms, means, and standard deviations. Possible risk factors for persistent diarrhea were analyzed as follows. For categorical risk factors, contingency tables were used and the strength of association was measured using the chi-square test statistic and its associated P value. For continuous risk factors, the Student t-test was used to compare the mean value of the risk factors in the study and control children.
Ethical considerations. The study was reviewed and approved by the Mulago Hospital Research and Ethics Committee. Relevant treatment was offered to the children and the attending pediatrician was advised of the results of the stool examinations. Children were followed-up until discharged from the hospital. No follow-up in the community was done because of budgetary constraints. Children meeting the inclusion criteria had their stools collected into sterile containers. Since there is no effective therapy for C. parvum, children with this infection were offered symptomatic treatment as well as relevant treatment for any concurrent infection.
| RESULTS |
|
|
|---|
Type of diarrhea. A total of 2,446 children were enrolled, of whom 1,779 (72.7%) had diarrhea and 667 (27.3%) were without diarrhea. Among the 1,779 children with diarrhea, 532 (29.9%) were classified as having persistent diarrhea (lasting 14 days or more) and 1,247 (70.1%) were classified as having acute diarrhea.
Sociodemographic characteristics.
The sociodemographic characteristics and age distribution of children with diarrhea attending Mulago Hospital are shown in Table 1
. The age distribution ranged between 3 and 36 months. It peaked at 10 months, then subsided after 36 months.
|
2 = 80.2, P
0.0001). The age distribution of children with cryptosporidiosis followed the same age distribution of children with diarrhea in this population (336 months). The PCR-RFLP analysis showed that of the 444 children with C. parvum, 326 (73.7%) were infected with genotype 1 (human), 85 (19.2%) with genotype 2 (zoonotic), and 19 (4.2%) with a mixture of genotypes 1 and 2. Fourteen (3%) isolates could not be classified as either genotype. Five isolates were classified as C. meleagridis.
|
14 days) versus acute diarrhea.
The mean duration of persistent diarrhea was 23.2 (SD = 13.66) days, while that of acute diarrhea was 4.79 (SD = 2.26) days. Of the 532 children with persistent diarrhea, 166 (31.2%) had cryptosporidiosis compared with 278 (22.3%) of the 1,247 children with acute diarrhea. This difference was statistically significant (
2 = 15.8, P < 0.0001).
Breastfeeding.
Among the children with diarrhea, 1,055 were still breastfeeding, and of these, 278 (26.4%) had C. parvum. Of the 724 children who were no longer breastfeeding, 210 (29.0%) had cryptosporidiosis. This difference was not statistically significant (
2 = 1.52, P = 0.217). However, among the five babies who were exclusively breastfeeding and had diarrhea, none had cryptosporidiosis. The mean age of the exclusively breast-fed children with diarrhea was 10.06 (SD = 6.62) months, while that of those with diarrhea but not exclusively breastfed was 10.49 (SD = 3.94) months. This difference was not statistically significant (P = 0.951).
Nutritional status and outcome.
The relationship between the nutritional status and cryptosporidiosis is summarized in Table 2
. Information on outcome was available on 736 (who were a subset of the 1,779) children with diarrhea. Unfavorable outcome was defined as either death or failure of the diarrhea to cease within two weeks. Of the 191 children with cryptosporidiosis, 139 (72.8%) had an unfavorable outcome, while among the 545 children without cryptosporidiosis, 355 (65.1%) had an unfavorable outcome (odds ratio = 1.117, 95% confidence interval = 1.0051.243,
2 = 3.738, P = 0.05).
Mortality.
Of the 444 children with cryptosporidiosis investigated, 191 were followed-up, of whom 24 (12.6%) died compared with 34 (6.2%) of the 545 without the infection, indicating that those with cryptosporidiosis had a significantly higher (
2 = 7.799, P = 0.005) mortality rate than those without the infection. However, it was difficult to determine with certainty whether the cause of death was due to cryptosporidiosis. The mortality rates were worse among stunted or underweight children with cryptosporidiosis than among those without C. parvum.
There was no significant difference among those with wasting (Tables 2
and 3
). Of the 203 with dehydration on admission, 33 (16.3%) died, while only 25 (4.8%) of the 521 without dehydration died, clearly indicating the risk faced by dehydrated children. Of the 267 children with persistent diarrhea, 31 (11.8%) died compared with only 27 (5.8%) of the 469 children with acute diarrhea (P = 0.005). Of the 144 children infected with C. parvum type 1, 17 (11.8%) died compared with 5 (13.9%) of the 36 children infected with type 2. Two of the 20 children with mixed infections with types 1 and 2 died. The numbers in this mixed group are too small to allow meaningful interpretation.
|
|
|
| DISCUSSION |
|
|
|---|
In the current study, we found a tight overlap between the age distribution of those with diarrhea and cryptosporidiosis. This was expected since a high proportion of the children 336 months of age acquire the infection for the first time.13 These results are consistent with studies from South Africa.21 The occurrence of C. parvum in a large proportion of diarrheic children less than three years of age has been reported in many of the developing countries, including those in sub-Saharan Africa.22 Children in developing countries, such as Uganda, become exposed to cryptosporidiosis within a few weeks after birth, and with maternal protection through breastfeeding, symptomatic infections sometimes are delayed until 624 months of age. While the protection afforded by continuous breastfeeding was not so apparent in the current study, none of the five babies who had diarrhea but were exclusively breast-fed had cryptosporidiosis.
There was a clear seasonal variation in the rate of detection of C. parvum, with the highest prevalence recorded in the rainy season between April and June. This seasonal variation has also been observed in the United States,13 Burkina Faso,19 and South Africa.21 It seems that after the primary infection, which is mostly symptomatic after three months of age, subsequent regular exposure to the parasite tends to be transient and asymptomatic, as shown in another study from Nigeria.22
The current study has shown cryptosporidiosis to be an important risk factor for malnutrition, including stunting, being underweight, and wasting. Similar results have been observed in Guinea-Bissau, where it was shown that cryptosporidiosis in children less than three years old can lead to a permanent growth retardation.23 In fact, C. parvum was more common among children with malnutrition and in non-breast-fed children in Mexico,24 and in non-breast-fed children with stunting in Bangladesh.4 Effective treatment against cryptosporidiosis is largely still unavailable, although nitazoxanide was recently shown in clinical trials to have some promise.8,9 Some of the 25% of the children with diarrhea due to cryptosporidiosis admitted to Mulago Hospital would have benefited from such a treatment, and it might have reduced the prospect of prolonged dehydration and the risk of wasting and death.
The contribution of prolonged cryptosporidiosis to malnutrition without apparent diarrhea is not clear and has received little attention. Given the extent and nature of the mucosal damage caused by C. parvum, it is more than likely to be significant. Unfortunately, children without diarrhea, even when malnourished, are seldom tested for the presence of enteric pathogens. Such an association can only be confirmed conclusively in cohort studies. The only evidence that asymptomatic cryptosporidiosis can cause retardation of weight gain comes from a single study in Peru.25 There have been several studies from Brazil linking persistent diarrhea associated with cryptosporidiosis and other agents with malnutrition.26 In particular, persistent diarrhea was shown in one study to result in long-term cognitive deficits in later years in children affected early in life.27 One limitation of the current study is the fact that we were, unfortunately, unable to carry out tests for infection with human immunodeficiency virus (HIV) on these children due to financial constraints. This means that it is not possible to stratify our findings with respect to HIV infection. However, based on recent preliminary observations, approximately 46% of the 65 children with persistent diarrhea seen in the wards in our study were HIV-positive, of whom 23% were excreting C. parvum oocysts (an ongoing study).
This study showed for the first time that there were no apparent clinical differences between children infected with types 1 and 2 of C. parvum. There were a few children who were infected with a mixture of the two types. Several isolates were identified that were neither type 1 nor type 2, but were most closely related to C. parvum based on molecular genetic analyses (Akiyoshi DE, Tzipori S, unpublished data). In addition, five non-C. parvum isolates were identified as C. meleagridis by molecular analyses.28 The presence of non-C. parvum isolates, including C. meleagridis, C. muris, C. felis, and a Cryptosporidium dog genotype from human infections, has been reported.2931 Genotype analysis of a subsample of type 1 and type 2 isolates using microsatellite polymorphisms identified several type 1 and type 2 alleles not seen among C. parvum from other geographic areas.20 In contrast to the wide distribution of microsatellite alleles observed to date, the Ugandan C. parvum haplotypes suggest that geographically restricted haplotypes are found in this study population.
Received September 20, 2002. Accepted for publication March 3, 2003.
Acknowledgment: We thank the staff of Mulago Hospital for their cooperation.
Financial support: This study was supported by National Institutes of Health grants NO1 AI-25466, 1 U01 AI-4648, and RO1 AI-50471.
Authors addresses: James K. Tumwine, Addy Kekitiinwa, and Nicolette Nabukeera, Department of Pediatrics and Child Health, Mulago Hospital, Makerere University Medical School, Kampala, Uganda. Donna E. Akiyoshi, Stephen M. Rich, Giovanni Widmer, Xiaochuan Feng, and Saul Tzipori, Division of Infectious Diseases, Tufts University School of Veterinary Medicine, 200 Westboro Road, North Grafton, MA 01536, Telephone: 508-839-7955, Fax: 508-839-7977, E-mail: saul.tzipori{at}tufts.edu
| REFERENCES |
|
|
|---|
This article has been cited by other articles:
![]() |
S. Tanriverdi, A. Grinberg, R. M. Chalmers, P. R. Hunter, Z. Petrovic, D. E. Akiyoshi, E. London, L. Zhang, S. Tzipori, J. K. Tumwine, et al. Inferences about the Global Population Structures of Cryptosporidium parvum and Cryptosporidium hominis Appl. Envir. Microbiol., December 1, 2008; 74(23): 7227 - 7234. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. HAQUE, S. ROY, A. SIDDIQUE, U. MONDAL, S. M. M. RAHMAN, D. MONDAL, E. HOUPT, and W. A. PETRI JR MULTIPLEX REAL-TIME PCR ASSAY FOR DETECTION OF ENTAMOEBA HISTOLYTICA, GIARDIA INTESTINALIS, AND CRYPTOSPORIDIUM SPP. Am J Trop Med Hyg, April 1, 2007; 76(4): 713 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. R. Ajjampur, B. P. Gladstone, D. Selvapandian, J. P. Muliyil, H. Ward, and G. Kang Molecular and Spatial Epidemiology of Cryptosporidiosis in Children in a Semiurban Community in South India J. Clin. Microbiol., March 1, 2007; 45(3): 915 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Meamar, K. Guyot, G. Certad, E. Dei-Cas, M. Mohraz, M. Mohebali, K. Mohammad, A. A. Mehbod, S. Rezaie, and M. Rezaian Molecular Characterization of Cryptosporidium Isolates from Humans and Animals in Iran Appl. Envir. Microbiol., February 1, 2007; 73(3): 1033 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. CHAPPELL, P. C. OKHUYSEN, R. LANGER-CURRY, G. WIDMER, D. E. AKIYOSHI, S. TANRIVERDI, and S. TZIPORI CRYPTOSPORIDIUM HOMINIS: EXPERIMENTAL CHALLENGE OF HEALTHY ADULTS Am J Trop Med Hyg, November 1, 2006; 75(5): 851 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Priest, C. Bern, L. Xiao, J. M. Roberts, J. P. Kwon, A. G. Lescano, W. Checkley, L. Cabrera, D. M. Moss, M. J. Arrowood, et al. Longitudinal Analysis of Cryptosporidium Species-Specific Immunoglobulin G Antibody Responses in Peruvian Children Clin. Vaccine Immunol., January 1, 2006; 13(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. SARFATI, A. BOURGEOIS, J. MENOTTI, F. LIEGEOIS, R. MOYOU-SOMO, E. DELAPORTE, F. DEROUIN, E. M. NGOLE, and J.-M. MOLINA PREVALENCE OF INTESTINAL PARASITES INCLUDING MICROSPORIDIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADULTS IN CAMEROON: A CROSS-SECTIONAL STUDY Am J Trop Med Hyg, January 1, 2006; 74(1): 162 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. TUMWINE, A. KEKITIINWA, S. BAKEERA-KITAKA, G. NDEEZI, R. DOWNING, X. FENG, D. E. AKIYOSHI, and S. TZIPORI CRYPTOSPORIDIOSIS AND MICROSPORIDIOSIS IN UGANDAN CHILDREN WITH PERSISTENT DIARRHEA WITH AND WITHOUT CONCURRENT INFECTION WITH THE HUMAN IMMUNODEFICIENCY VIRUS Am J Trop Med Hyg, November 1, 2005; 73(5): 921 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Sulaiman, P. R. Hira, L. Zhou, F. M. Al-Ali, F. A. Al-Shelahi, H. M. Shweiki, J. Iqbal, N. Khalid, and L. Xiao Unique Endemicity of Cryptosporidiosis in Children in Kuwait J. Clin. Microbiol., June 1, 2005; 43(6): 2805 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Johnson, K. Linden, K. M. Ciociola, R. De Leon, G. Widmer, and P. A. Rochelle UV Inactivation of Cryptosporidium hominis as Measured in Cell Culture Appl. Envir. Microbiol., May 1, 2005; 71(5): 2800 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hashim, M. Clyne, G. Mulcahy, D. Akiyoshi, R. Chalmers, and B. Bourke Host Cell Tropism Underlies Species Restriction of Human and Bovine Cryptosporidium parvum Genotypes Infect. Immun., October 1, 2004; 72(10): 6125 - 6131. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. KHAN, K. A. ROGERS, M. M. KARIM, S. AHMED, P. L. HIBBERD, S. B. CALDERWOOD, E. T. RYAN, and H. D. WARD CRYPTOSPORIDIOSIS AMONG BANGLADESHI CHILDREN WITH DIARRHEA: A PROSPECTIVE, MATCHED, CASE-CONTROL STUDY OF CLINICAL FEATURES, EPIDEMIOLOGY AND SYSTEMIC ANTIBODY RESPONSES Am J Trop Med Hyg, October 1, 2004; 71(4): 412 - 419. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |